To arrange an interview, please contact the NHLBI Communications Office at 301-496-4236 or email@example.com.
George A. Mensah, M.D., FACC, is director of the Center for Translation Research and Implementation Science (CTRIS) at the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH).
As director of CTRIS, Dr. Mensah leads an integrative, trans-Institute effort to advance the translation of scientific discoveries in heart, lung, and blood diseases research to clinical and public health practice nationally and globally. CTRIS will address its mission by investing in research that shows how fundamental scientific discoveries and interventions of proven effectiveness can best be applied in hospitals, homes, worksites, and the community at large to maximize population health impact.
Dr. Mensah is a clinician-scientist trained in internal medicine and the subspecialty of cardiovascular diseases. His professional experience includes 17 years of public service between the U.S. Department of Veterans Affairs (VA) and the Centers for Disease Control and Prevention (CDC). He has had management experience as a chief of cardiology; head of a clinical care department; and the Surgeon General’s nominee to the Board of Governors of the American College of Cardiology as governor for public health.
In addition to his public service at CDC, Dr. Mensah has 10 years of experience in direct patient care, teaching, and research at Vanderbilt University and the Medical College of Georgia (MCG). He was a professor with tenure at MCG, director of the medical specialties practice at the MCG Hospitals & Clinics, and department head of cardiovascular care at the VA Medical Center in Augusta, Georgia. He holds a merit of proficiency from the American Society of Echocardiography and has been designated a “hypertension specialist” by the American Society of Hypertension.
During his nine years at CDC, Dr. Mensah held several leadership positions, including the first chief of the Cardiovascular Health Branch; an interim center director; and chief medical officer at the National Center for Chronic Disease Prevention and Health Promotion. Most recently, he served as vice president for nutrition science within the global research and development unit of a major multinational food and beverage company. Dr. Mensah is adept at motivating and energizing local and global teams and fostering results-oriented strategy execution. He excels at building partnerships with a variety of organizations.
During the course of his career, Dr. Mensah has authored more than 400 manuscripts, abstracts, book chapters, and an atlas on heart disease and stroke published by the World Health Organization (WHO) and CDC. He recently served as chairman of the Cardiovascular Expert Group of the Global Burden of Diseases, Injuries, and Risk Factors Study. This group of study collaborators is a consortium that includes the Institute for Health Metrics and Evaluation at the University of Washington, Harvard University, Johns Hopkins University, the University of Queensland, and the WHO. The collaboration includes nearly 500 researchers from more than 300 institutions in over 50 countries.
September 9, 2014
NIH-convened panel recommends expanded adoption of drug and transfusion treatments for individuals with sickle cell disease
An expert panel has recommended expanded adoption of the drug hydroxyurea for the care of people with sickle cell disease, according to a report issued today. The report also suggests that clinicians give periodic blood transfusions to children with the disease to reduce stroke risk. According to the panel, both treatments are underutilized.
November 14, 2013
: The New York Times
Crayons down. Now dig into that healthful parfait.
A new obesity prevention initiative by the Children’s Museum of Manhattan in collaboration with the National Institutes of Health seeks to teach children who cannot yet spell the names of their fruits and vegetables to love them and eat them every day.